Pharyngocutaneous fistulas after total laryngectomy or pharyngolaryngectomy: Place of video-fluoroscopic swallowing study.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
12 2020
Historique:
received: 03 12 2019
revised: 18 06 2020
accepted: 03 08 2020
pubmed: 31 8 2020
medline: 22 6 2021
entrez: 1 9 2020
Statut: ppublish

Résumé

Specify place of video-fluoroscopic swallowing study (VFS) in the decision of oral refeeding after total pharyngolaryngectomy. At postoperative day 7, a blue dye testing was performed. If negative, a VFS was performed looking for a blind fistula. If this exam was negative, oral refeeding was started, but if a blind fistula was observed, cervical compression bandage was performed. In 186 patients, a VFS was performed for 142 patients with negative blue dye testing. It was negative for 98 patients (69%) and positive for 44 patients (31%) (blind fistula). Patients had a probability of 7.1% to have a secondary pharyngocutaneous fistula (PCF) if the VFS was negative, and 15.9% if it was positive. No risk factor for the development of a secondary PCF or a blind fistula emerged from our analysis. VFS should be performed before any oral refeeding in all patients operated with a total pharyngolaryngectomy.

Sections du résumé

BACKGROUND
Specify place of video-fluoroscopic swallowing study (VFS) in the decision of oral refeeding after total pharyngolaryngectomy.
METHODS
At postoperative day 7, a blue dye testing was performed. If negative, a VFS was performed looking for a blind fistula. If this exam was negative, oral refeeding was started, but if a blind fistula was observed, cervical compression bandage was performed.
RESULTS
In 186 patients, a VFS was performed for 142 patients with negative blue dye testing. It was negative for 98 patients (69%) and positive for 44 patients (31%) (blind fistula). Patients had a probability of 7.1% to have a secondary pharyngocutaneous fistula (PCF) if the VFS was negative, and 15.9% if it was positive. No risk factor for the development of a secondary PCF or a blind fistula emerged from our analysis.
CONCLUSION
VFS should be performed before any oral refeeding in all patients operated with a total pharyngolaryngectomy.

Identifiants

pubmed: 32864848
doi: 10.1002/hed.26429
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3638-3646

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Krouse JH, Metson R. Barium swallow is a predictor of salivary fistula following laryngectomy. Otolaryngol Head Neck Surg. 1992;106:254-257.
Cavalot AL, Gervasio CF, Nazionale G, et al. Pharyngocutaneous fistula as a complication of total laryngectomy: review of the literature and analysis of case records. Otolaryngol Head Neck Surg. 2000;123:587-592.
Saydam L, Kalcioglu T, Kizilay A. Early oral feeding following total laryngectomy. Am J Otolaryngol. 2002;23:277-281.
Soylu L, Kiroglu M, Aydogan B, et al. Pharyngocutaneous fistula following laryngectomy. Head Neck. 1998;20:22-25.
Kiong KL, Tan NC, Skanthakumar T, Teo CEH, Soo KC. Salivary fistula: blue dye testing as part of an algorithm for early diagnosis. Laryngosc Invest Otolaryngol. 2017;12(2):363-368.
Saki N, Nikakhlagh S, Kazemi M. Pharyngocutaneous fistula after laryngectomy: incidence, predisposing factors, and outcome. Arch Iran Med. 2008;11:314-317.
Virtaniemi JA, Kumpulainen EJ, Hirvikoski PP, Johansson RT, Kosma VM. The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae. Head Neck. 2001;23:29-33.
Sousa Ade A, Porcaro-Salles JM, Soares JM, et al. Predictors of salivary fistula after total laryngectomy. Rev Col Bras Cir. 2013;40(2):98-103.
Galli J, De Corso E, Volante M, Almadori G, Paludetti G. Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy. Otolaryngol Head Neck Surg. 2005;133:689-694.
Redaelli de Zinis LO, Ferrari L, Tomenzoli D, Premoli G, Parrinello G, Nicolai P. Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy. Head Neck. 1999;21:131-138.
Ganly I, Patel S, Matsuo J, et al. Postoperative complications of salvage total laryngectomy. Cancer. 2005;103:2073-2081.
Grau C, Johansen LV, Hansen HS, et al. Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA. Head Neck. 2003;25:711-716.
Friedman M, Venkatesan TK, Yakovlev A, Lim JW, Tanyeri HM, Caldarelli DD. Early detection and treatment of postoperative pharyngocutaneous fistula. Otolaryngol Head Neck Surg. 1999;121:378-380.
White HN, Golden B, Sweeny L, Carroll WR, Magnuson JS, Rosenthal EL. Assessment and incidence of salivary leak following laryngectomy. Laryngoscope. 2012;122:1796-1799.
Moses BL, Eisele DW, Jones B. Radiologic assessment of the early postoperative total-laryngectomy patient. Laryngoscope. 1993;103:1157-1160.
Qureshi SS, Chaturvedi P, Pai PS, et al. A prospective study of pharyngocutaneous fistulas following total laryngectomy. J Cancer Res Ther. 2005;1:51-56.
Wakisaka N, Murono S, Kondo S, Furukawa M, Yoshizaki T. Post-operative pharyngocutaneous fistula after laryngectomy. Auris Nasus Larynx. 2008;35:203-208.
Esteban F, Delgado-Rodriguez M, Mochon A, Solano J, Soldado L, Solanellas J. Study of in-patient hospital stay following total laryngectomy: multivariable retrospective analysis of a 442 total laryngectomies. Acta Otorrinolaringol Esp. 2006;57:176-182.
Dequanter D, Lothaire P, Philippart P, et al. Fistula and stenosis after 135 (pharyngo)laryngectomies. Acta Chir Belg. 2008;108:98-101.
Palomar-Asenjo V, Sarroca Capell E, Tobias Gomez S, Perez Hernandez I, Palomar-Garcia V. Pharyngocutaneous fistula following total laryngectomy. A case-control study of risk factors implicated in its onset. Acta Otorrinolaringol Esp. 2008;59:480-484.
Aires FT, Dedivitis RA, Kulcsar MAV, Ramos DEM, Cernea CR. Neutrophil-to-lymphocyte ratio as a pronostic factor for pharyngocutaneous fistula after total laryngectomy. Acta Otorhinolaryngol Ital. 2018;38:31-37.
Stephenson K, Fagan J. Effect of perioperative proton pump inhibitors on the incidence of pharyngocutaneous fistula after total laryngectomy: a prospective randomized controlled trial. Head Neck. 2015;37(2):225-229.
Muller-Miny H, Eisele DW, Jones B. Dynamic radiographic imaging following total laryngectomy. Head Neck. 1993;15:342-347.
Balfe DM, Koehler RE, Setzen M, Weyman PJ, Baron RL, Ogura JH. Barium examination of the esophagus after total laryngectomy. Radiology. 1982;143:501-508.
van la Parra RF, Kon M, Schellekens PP, Braunius WW, Pameijer FA. The prognostic value of abnormal findings on radiographic swallowing studies after total laryngectomy. Cancer Imaging. 2007;7:119-125.
Martin S, Jordan Z, Carney SA. The effect of early oral feeding compared to standard oral feeding following total laryngectomy: a systematic review. JBI Database Syst Rev Implement Rep. 2013;11(11):140-182.
Guimarães AV, Aires FT, Dedivitis RA, et al. Efficacy of pectoralis major muscle flap for pharyngocutaneous fistula prevention in salvage total laryngectomy: a systematic review. Head Neck. 2016;38(supp 1):E2317-E2321.
Paleri V, Drinnan M, Van Den Brekel MW, et al. Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope. 2014;124(8):1848-1853.
Sayles M, Grant DG. Preventing pharyngo-cutaneous fistula in total laryngectomy: a systematic review and meta-analysis. Laryngoscope. 2014;124(5):1150-1163.
Paydarfar JA, Birkmeyer NJ. Complications in head and neck surgery: a meta-analysis of postlaryngectomy pharyngocutaneous fistula. Arch Otolaryngol Head Neck Surg. 2006;132:67-72.

Auteurs

Florent Carsuzaa (F)

Head and Neck Surgery, University Hospital of Poitiers, Poitiers, France.

Anne-Laure Capitaine (AL)

Head and Neck Surgery, Hospital of La Rochelle, La Rochelle, France.

Jean-Claude Ferrié (JC)

Radiology and Diagnostic Imaging, University Hospital of Poitiers, Poitiers, France.

Vincent Apert (V)

Head and Neck Surgery, Hospital of Niort, Niort, France.

Denis Tonnerre (D)

Head and Neck Surgery, University Hospital of Poitiers, Poitiers, France.

Denis Frasca (D)

Anesthesiology, University Hospital of Poitiers, Poitiers, France.
Data Biostatistics Department, University Hospital of Poitiers, Poitiers, France.
INSERM UMR-1246, Universities of Nantes and Tours, Tours, France.

Xavier Dufour (X)

Head and Neck Surgery, University Hospital of Poitiers, Poitiers, France.
Laboratoire Inflammation Tissus Epitheliaux et Cytokines EA4331, University of Poitiers, Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH